APA

Hillebrenner E., Litwack E., Bradley P., Donigan K., Lowe T., Serrano K., Kelm K., Mansfield E. & Gutierrez A. (20160314). FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care. : Journal of clinical pharmacology.

Chicago

Hillebrenner E, Litwack E, Bradley P, Donigan K, Lowe T, Serrano K, Kelm K, Mansfield E and Gutierrez A. 20160314. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care. : Journal of clinical pharmacology.

Harvard

Hillebrenner E., Litwack E., Bradley P., Donigan K., Lowe T., Serrano K., Kelm K., Mansfield E. and Gutierrez A. (20160314). FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care. : Journal of clinical pharmacology.

MLA

Hillebrenner E, Litwack E, Bradley P, Donigan K, Lowe T, Serrano K, Kelm K, Mansfield E and Gutierrez A. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care. : Journal of clinical pharmacology. 20160314.